Correlation
The correlation between CC and IOSP is 0.53, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
CC vs. IOSP
Compare and contrast key facts about The Chemours Company (CC) and Innospec Inc. (IOSP).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: CC or IOSP.
Performance
CC vs. IOSP - Performance Comparison
Loading data...
Key characteristics
CC:
-1.00
IOSP:
-1.01
CC:
-1.83
IOSP:
-1.46
CC:
0.79
IOSP:
0.82
CC:
-0.77
IOSP:
-0.91
CC:
-1.88
IOSP:
-1.75
CC:
31.84%
IOSP:
18.72%
CC:
58.79%
IOSP:
31.83%
CC:
-86.15%
IOSP:
-91.17%
CC:
-76.15%
IOSP:
-34.20%
Fundamentals
CC:
$1.52B
IOSP:
$2.15B
CC:
$0.18
IOSP:
$1.06
CC:
56.28
IOSP:
80.26
CC:
1.67
IOSP:
-2.95
CC:
0.26
IOSP:
1.20
CC:
2.62
IOSP:
1.69
CC:
$5.80B
IOSP:
$1.79B
CC:
$1.10B
IOSP:
$512.30M
CC:
$640.00M
IOSP:
$201.50M
Returns By Period
In the year-to-date period, CC achieves a -38.57% return, which is significantly lower than IOSP's -21.96% return.
CC
-38.57%
-16.30%
-52.24%
-57.03%
-35.83%
-1.38%
N/A
IOSP
-21.96%
-4.59%
-27.59%
-33.90%
-4.56%
3.35%
8.41%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
CC vs. IOSP — Risk-Adjusted Performance Rank
CC
IOSP
CC vs. IOSP - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for The Chemours Company (CC) and Innospec Inc. (IOSP). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Loading data...
Dividends
CC vs. IOSP - Dividend Comparison
CC's dividend yield for the trailing twelve months is around 8.27%, more than IOSP's 1.92% yield.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CC The Chemours Company | 8.27% | 5.92% | 3.17% | 3.27% | 2.98% | 4.03% | 5.53% | 2.98% | 0.24% | 0.54% | 10.82% | 0.00% |
IOSP Innospec Inc. | 1.92% | 1.41% | 1.14% | 1.24% | 1.28% | 1.15% | 0.99% | 1.44% | 1.09% | 0.98% | 1.12% | 1.29% |
Drawdowns
CC vs. IOSP - Drawdown Comparison
The maximum CC drawdown since its inception was -86.15%, smaller than the maximum IOSP drawdown of -91.17%. Use the drawdown chart below to compare losses from any high point for CC and IOSP.
Loading data...
Volatility
CC vs. IOSP - Volatility Comparison
The Chemours Company (CC) has a higher volatility of 18.61% compared to Innospec Inc. (IOSP) at 7.31%. This indicates that CC's price experiences larger fluctuations and is considered to be riskier than IOSP based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading data...
Financials
CC vs. IOSP - Financials Comparison
This section allows you to compare key financial metrics between The Chemours Company and Innospec Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
CC vs. IOSP - Profitability Comparison
CC - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2025, The Chemours Company reported a gross profit of 236.00M and revenue of 1.37B. Therefore, the gross margin over that period was 17.3%.
IOSP - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2025, Innospec Inc. reported a gross profit of 125.10M and revenue of 440.80M. Therefore, the gross margin over that period was 28.4%.
CC - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2025, The Chemours Company reported an operating income of 78.00M and revenue of 1.37B, resulting in an operating margin of 5.7%.
IOSP - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2025, Innospec Inc. reported an operating income of 42.50M and revenue of 440.80M, resulting in an operating margin of 9.6%.
CC - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2025, The Chemours Company reported a net income of -4.00M and revenue of 1.37B, resulting in a net margin of -0.3%.
IOSP - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2025, Innospec Inc. reported a net income of 32.80M and revenue of 440.80M, resulting in a net margin of 7.4%.